Blog

  • ACASTI Pharmaceuticals – countdown is on to Phase (3) trial results

    October 26, 2019 | Posted by

    We have written extensively about Acasti Pharma per HERE and it has been one of our most successful trades this year – we are effectively now “in for free” (always the best position to be in emotionally) following the near 6 fold increase from lows below 50c to near $3 at the peak in mid […]

  • EXMceuticals – Further operational progress across Portugal and Africa

    October 25, 2019 | Posted by

    By Richard Gill, CFA EXMceuticals Inc. (CSE: EXM), is a Canada listed cultivator and producer of high-grade cannabis, with its cultivation operations focussed in several countries in Central/Southern Africa, including Uganda, Malawi and the Democratic Republic of the Congo. In Portugal, the company has a research laboratory, nursery and a centre for processing and distribution, […]

  • Pathfinder Minerals Update – resolution looks to be finally in sight

    October 24, 2019 | Posted by

    The RNS out this morning from Pathfinder Minerals per HERE should provide material comfort to patient shareholders that the end is now finally in sight with regards to the tortuous licence resolution issue. The key takeaways are as follows: 1. A negotiated settlement is in ALL parties interests – Pathfinder Mozambique, PFP & Mozambique as […]

  • Metro Bank 3Q results – looks like one in the eye for the shorts

    October 23, 2019 | Posted by

    Results out this afternoon from Metro Bank could not, it seems to us, have been more devastating for the shorts and naysayers of the stock. Key takeaway’s are as follows: 1. Continued strong customer growth (increase of 109k accounts to 1.9m) 2. Contrary to the most vocal bears, net deposits actually grew by just over […]

  • Align Research – Statement re Vox Markets

    October 10, 2019 | Posted by

    We note the RNS released by PCG Entertainment Plc this morning which is defamatory and thus respond as below: The proposed combine of Align/Vox/PCGE had in fact raised sufficient funds that were required for the reverse transaction in accordance with the working capital requirements. This raising was largely through Align Research’s connections and efforts. Termination […]

Loading More